This insider cluster is too small to warrant a trading signal. Monitor for any material corporate events (earnings, pipeline updates, M&A) that could explain the sales, but the dollar amount is routine for a large-cap biopharma. No immediate action needed.
GILD drugs
GILD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 17 $125.45entry
- T+1 · 5mo ago −1.35%α −2.13% · $123.76
- T+5 · 5mo ago −0.23%α +0.81% · $125.16
- T+20 · 4mo ago +8.65%α +7.33% · $136.30
- T+60 · 2mo ago +14.56%α +11.41% · $143.72
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two GILD executives (CFO and Chief Communications & Corporate Affairs Officer) sold a combined $559K in open-market shares on June 15, 2026. The dollar amount is negligible relative to GILD's $154B market cap (0.00036%), and the sales are likely routine portfolio adjustments rather than a bearish signal. Non-cash derivative exercises and tax-withholding transactions by the CEO and other officers on June 10 are standard compensation events with no economic impact.
Key Financial Metrics
Key Facts
- CFO Andrew Dickinson sold 3,000 shares at $125.40 for $376K on June 15.
- Chief Comm & Corp Aff Officer Johanna Mercier sold 1,480 shares at $123.42 for $183K on June 15.
- Total open-market sales: $559K, representing 0.00036% of market cap.
- CEO Daniel O'Day and other executives exercised options and surrendered shares for tax withholding on June 10, non-cash events.
Financial Impact
Negligible, $559K in insider sales against $154B market cap.
Risk Factors
- Insider sales could precede negative news, but the tiny size makes this unlikely.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GILD-1781647358670 |
Track record
30 reports on GILD
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
- Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
- Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers